Developing novel biologics to target and eliminate key drivers of cancer recurrence and metastasis. Blending early-stage research with innovative platform design to develop next-generation treatments to eliminate the most resilient cancers.

Developing novel biologics to target and eliminate key drivers of cancer recurrence and metastasis. Blending early-stage research with innovative platform design to develop next-generation treatments to eliminate the most resilient cancers.